Michael D Schneider
Overview
Explore the profile of Michael D Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
9959
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneider M, Dorn G
Cardiovasc Res
. 2023 Feb;
119(2):e118-e119.
PMID: 36790900
No abstract available.
2.
Miranda A, Janbandhu V, Maatz H, Kanemaru K, Cranley J, Teichmann S, et al.
Nat Rev Cardiol
. 2022 Dec;
20(5):289-308.
PMID: 36539452
Cardiovascular disease is the leading cause of death globally. An advanced understanding of cardiovascular disease mechanisms is required to improve therapeutic strategies and patient risk stratification. State-of-the-art, large-scale, single-cell and...
3.
Te Lintel Hekkert M, Newton G, Chapman K, Aqil R, Downham R, Yan R, et al.
Basic Res Cardiol
. 2021 May;
116(1):34.
PMID: 34018053
Reducing infarct size (IS) by interfering with mechanisms for cardiomyocyte death remains an elusive goal. DMX-5804, a selective inhibitor of the stress-activated kinase MAP4K4, suppresses cell death in mouse myocardial...
4.
5.
Forte E, Perkins B, Sintou A, Kalkat H, Papanikolaou A, Jenkins C, et al.
Circulation
. 2020 Dec;
143(8):821-836.
PMID: 33297741
Background: Ischemic heart disease is a leading cause of heart failure and despite advanced therapeutic options, morbidity and mortality rates remain high. Although acute inflammation in response to myocardial cell...
6.
Lawlor K, Marques-Torrejon M, Dharmalingham G, El-Azhar Y, Schneider M, Pollard S, et al.
Genes Dev
. 2020 Nov;
34(23-24):1599-1604.
PMID: 33184225
There is increasing evidence demonstrating that adult neural stem cells (NSCs) are a cell of origin of glioblastoma. Here we analyzed the interaction between transformed and wild-type NSCs isolated from...
7.
Che J, Najer A, Blakney A, McKay P, Bellahcene M, Winter C, et al.
Adv Mater
. 2020 Oct;
32(48):e2003598.
PMID: 33103807
Uncontrolled inflammation is a major pathological factor underlying a range of diseases including autoimmune conditions, cardiovascular disease, and cancer. Improving localized delivery of immunosuppressive drugs to inflamed tissue in a...
8.
Adamowicz M, Morgan C, Haubner B, Noseda M, Collins M, Abreu Paiva M, et al.
Circ Genom Precis Med
. 2020 Sep;
11(2):e001805.
PMID: 32966096
Background: The adult mammalian heart has little regenerative capacity after myocardial infarction (MI), whereas neonatal mouse heart regenerates without scarring or dysfunction. However, the underlying pathways are poorly defined. We...
9.
Constantinou C, Miranda A, Chaves P, Bellahcene M, Massaia A, Cheng K, et al.
Sci Rep
. 2020 Aug;
10(1):13016.
PMID: 32747668
Ischemic heart disease remains the foremost cause of death globally, with survivors at risk for subsequent heart failure. Paradoxically, cell therapies to offset cardiomyocyte loss after ischemic injury improve long-term...
10.
Golforoush P, Narasimhan P, Chaves-Guerrero P, Lawrence E, Newton G, Yan R, et al.
Sci Rep
. 2020 Jul;
10(1):12060.
PMID: 32694738
Given the poor track record to date of animal models for creating cardioprotective drugs, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have been proposed as a therapeutically relevant human platform to...